(2-methyl-butyl)-phenyl ether | 91967-72-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: (2-methyl-butyl)-phenyl ether
• 英文别名: (2-Methyl-butyl)-phenyl-aether；(+)-(2-Methylbutyl)phenylether；2-Methyl-butoxy-benzene；2-methylbutoxybenzene
• CAS: 91967-72-5
• 化学式: C₁₁H₁₆O
• 分子量: 164.247
• InChiKey: CHCGWVHHRJNLRE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  (2-methyl-butyl)-phenyl ether 生成 4-(2-Methylbutoxy)benzenesulfonyl chloride
  参考文献：
  名称：

  JOSINAGA, KADZUO;KATAGIRI, KADZUXARU;KOBAYASI, TOEKO

  摘要：

  DOI：
• 作为产物：
  描述：

  S-(-)-2-甲基-1-丁醇 在 溴 、 sodium ethanolate 作用下， 以 乙醇 为溶剂， 生成 (2-methyl-butyl)-phenyl ether
  参考文献：
  名称：

  Pathak,U.S.; Thakar,K.A., Journal of the Indian Chemical Society, 1964, vol. 41, p. 534 - 536

  摘要：

  DOI：

文献信息

• 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle
  申请人：Sekiguchi Yoshinori

  公开号：US20080318923A1

  公开（公告）日：2008-12-25

  It is intended to provide a drug which is efficacious against pathological conditions relating to arginine-vasopressin V1b receptor. More particularly speaking, it is intended to provide a drug which has a therapeutic or preventive effect on depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorders, hypertension, digestive diseases, drug addiction, epilepsy, brain infarction, brain ischemia, brain edema, head injury, inflammation, immune diseases, alopecia and so on. As the results of intensive studies, a novel 1,3-dihydro-2H-indol-2-one compound and a pyrrolidin-2-one compound fused with a heteroaromatic ring, which are highly selective antagonists of arginine-vasopressin V1b receptor, have high metabolic stabilities and show favorable brain penetration and high plasma concentrations, are found, thereby achieving the above objective.

  旨在提供一种对与精氨酸加压素V1b受体相关的病理状况具有疗效的药物。更具体地说，旨在提供一种对抑郁症、焦虑症、阿尔茨海默病、帕金森病、亨廷顿舞蹈症、进食障碍、高血压、消化系统疾病、药物成瘾、癫痫、脑梗死、脑缺血、脑水肿、头部损伤、炎症、免疫疾病、脱发等具有治疗或预防作用的药物。经过深入研究，发现了一种新颖的1,3-二氢-2H-吲哚-2-酮化合物和与杂芳环融合的吡咯烷-2-酮化合物，它们是高度选择性的精氨酸加压素V1b受体拮抗剂，具有高代谢稳定性，表现出有利的血脑屏障穿透和高血浆浓度，从而实现了上述目标。
• CARBAMATE-METHACRYLATE MONOMERS AND THEIR USE IN DENTAL APPLICATIONS
  申请人：Trujillo-Lemon Marianela

  公开号：US20100307378A1

  公开（公告）日：2010-12-09

  The present invention relates, generally, to monomers containing carbamate-methacrylates or derivatives of carbamate-methacrylates, processes for making the monomers, and compositions comprising the monomers. The present invention also relates to methods of using the monomers, such as in dental applications, and in particular, dental restorative resins.

  本发明涉及含有碳酸酯-甲基丙烯酸酯或碳酸酯-甲基丙烯酸酯衍生物的单体，制备该单体的方法以及包含该单体的组合物。本发明还涉及使用该单体的方法，例如在牙科应用中，特别是在牙科修复树脂中的应用。
• Alkoxy-substituted indanes and the production thereof
  申请人：Koch Oskar

  公开号：US20050107476A1

  公开（公告）日：2005-05-19

  The present invention relates to alkoxy-substituted indanes, their preparation and use and to the preparation and use of the corresponding alkoxy-substituted indanones.

  本发明涉及烷氧基取代的茚烷，其制备和使用，以及相应的烷氧基取代的茚酮的制备和使用。
• Verfahren zur Herstellung von hochmolekularen, gegebenenfalls verzweigten Polyarylensulfiden
  申请人：BAYER AG

  公开号：EP0275007A2

  公开（公告）日：1988-07-20

  Die Erfindung betrifft ein Verfahren zur Herstellung von hochmolekularem, gegebenenfalls verzweigten Polyarylen­sulfiden aus Alkalisulfiden, gegebenenfalls im Gemisch mit Alkalihydrogensulfiden und Dihalogenaromaten in einem polaren Lösungsmittel, in Gegenwart von 0,1 bis 6,0 Mol-%, bevorzugt 0,25 bis 4,0 Mol-% einer aromati­schen Monoalkoxy- bzw. Monoalkylthioverbindung. Die so erhaltenen Polyarylensulfide haben reproduzierbar ein­stellbare Schmelzviskositäten bzw. Molmassen und zeich­nen sich durch eine geringere Korrosion aus.

  本发明涉及一种以碱金属硫化物为原料，在极性溶剂中与碱金属硫化氢和二卤代芳烃混合，在 0.1 至 6.0 摩尔%，最好是 0.25 至 4.0 摩尔%的芳香族单烷氧基或单烷基硫代化合物存在下制备高分子量、可选择支化的聚芳基硫化物的工艺。通过这种方法获得的聚芳基硫化物具有可重复调节的熔体粘度或摩尔质量，并具有较低的腐蚀性。
• Method for producing an aromatic compound having an alkyl group with at least three carbon atoms
  申请人：TORAY INDUSTRIES, INC.

  公开号：EP0985649A2

  公开（公告）日：2000-03-15

  Aromatic compounds having an alkyl group with at least 3 carbon atoms are produced in a process comprising at least one of the following steps: (1) a step of contacting a starting material that contains an aromatic compound having a branched alkyl group with at least 3 carbon atoms, with a zeolite-containing catalyst in a liquid phase in the presence of hydrogen therein, thereby changing the position of the carbon atoms of the alkyl group bonding to the aromatic ring of the compound; (2) a step of contacting a starting material that contains an aromatic compound having a branched alkyl group with at least 3 carbon atoms, with a catalyst containing zeolite and containing rhenium and/or silver, in a liquid phase, thereby changing the position of the carbon atoms of the alkyl group bonding to the aromatic ring of the compound; (3) a step of contacting a halogenated aromatic compound having an alkyl group with at least 3 carbon atoms, with an acid-type catalyst, thereby isomerizing the compound; and (4) a step of treating a mixture of isomers of an aromatic compound having an alkyl group with at least 3 carbon atoms, with a zeolite adsorbent that contains at least one exchangable cation selected from alkali metals, alkaline earth metals, lead, thallium and silver, thereby separating a specific isomer from the isomer mixture through adsorption.

  具有至少 3 个碳原子烷基的芳香族化合物的生产工艺至少包括以下一个步骤： (1) 将含有至少 3 个碳原子的支链烷基的芳香族化合物的起始原料在液相中与含沸石的催化剂在氢存在的情况下接触，从而改变烷基的碳原子与化合物的芳香环键合的位置； (2) 将含有芳香族化合物的起始原料与含沸石和含铼和/或银的催化剂在液相中接触，该芳香族化合物具有至少 3 个碳原子的支链烷基，从而改变烷基碳原子与化合物芳香环键合的位置； (3) 将具有至少 3 个碳原子的烷基的卤代芳香族化合物与酸型催化剂接触，从而使该化合物异构化；以及 (4) 用沸石吸附剂处理具有至少 3 个碳原子的烷基的芳香族化合物的异构体混合物，该沸石吸附剂含有至少一种选自碱金属、碱土金属、铅、铊和银的可交换阳离子，从而通过吸附从异构体混合物中分离出特定的异构体。